Achievement of Durable and Complete Remission of Graft-versus-host Disease After Liver Transplantation With Ruxolitinib: A Case Report

Transplantation. 2019 Nov;103(11):e375-e377. doi: 10.1097/TP.0000000000002904.

Authors

Yutaka Endo¹, Go Oshima¹, Taizo Hibi², Masahiro Shinoda¹, Masatoshi Sakurai³, Yuya Koda³, Yoshikane Izawa⁴, Hideaki Obara¹, Minoru Kitago¹, Hiroshi Yagi¹, Yuta Abe¹, Kentaro Matsubara¹, Yohei Yamada⁵, Ayano Fukushima⁶, Takahiro Yokose¹, Takehiko Mori³, Tatsuo Kuroda⁵, Yuko Kitagawa¹

Affiliations

¹ Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
² Department of Pediatric Surgery and Transplantation, Kumamoto University School of Medicine, Kumamoto, Japan.
³ Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
⁴ Division of Neurology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
⁵ Department of Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan.
⁶ Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

PMID: 31397803
DOI: 10.1097/TP.0000000000002904

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adrenal Cortex Hormones / metabolism
Adult
Brain Diseases / complications
Cholangitis, Sclerosing / surgery*
Colitis / virology
Cytomegalovirus Infections / complications
Enzyme Inhibitors / therapeutic use
Female
Graft Survival
Graft vs Host Disease / therapy*
Herpesvirus 6, Human
Humans
Liver Transplantation / adverse effects*
Male
Middle Aged
Nitriles
Postoperative Complications
Pyrazoles / therapeutic use*
Pyrimidines
Remission Induction
Roseolovirus Infections / complications
Treatment Outcome

Substances

Adrenal Cortex Hormones
Enzyme Inhibitors
Nitriles
Pyrazoles
Pyrimidines
ruxolitinib